VFA
Virtus Fund Advisers Portfolio holdings
AUM
$32.1M
1-Year Return
39.5%
This Quarter Return
+5.84%
1 Year Return
+39.5%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$10.2B
AUM Growth
+$370M
(+3.8%)
Cap. Flow
-$163M
Cap. Flow
% of AUM
-1.6%
Top 10 Holdings %
Top 10 Hldgs %
14%
Holding
622
New
136
Increased
89
Reduced
249
Closed
24
Top Buys
| 1 |
Republic Services
RSG
|
$97.7M |
| 2 |
BP
BP
|
$71.4M |
| 3 |
FRC
First Republic Bank
FRC
|
$67.4M |
| 4 |
Kraft Heinz
KHC
|
$61.8M |
| 5 |
APC
Anadarko Petroleum
APC
|
$59.6M |
Top Sells
| 1 |
Edison International
EIX
|
$74.9M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
$70.7M |
| 3 |
RGC
Regal Entertainment Group
RGC
|
$64.6M |
| 4 |
SCG
Scana
SCG
|
$63.3M |
| 5 |
Bankunited
BKU
|
$62.6M |
Sector Composition
| 1 | Industrials | 15.8% |
| 2 | Financials | 14.95% |
| 3 | Technology | 10.39% |
| 4 | Healthcare | 9.6% |
| 5 | Energy | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Lexicon Pharmaceuticals
LXRX
$396M
| $939K | 0.01% |
+95,079
| New | +$939K |
|
302
Ionis Pharmaceuticals
IONS
$9.76B
| $936K | 0.01% |
+18,610
| New | +$936K |
|
303
Regeneron Pharmaceuticals
REGN
$60.8B
| $936K | 0.01% |
+2,490
| New | +$936K |
|
304
Travere Therapeutics
TVTX
$1.93B
| $933K | 0.01% |
+44,297
| New | +$933K |
|
|
ICPT
305
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $908K | 0.01% |
+15,542
| New | +$908K |
|
306
Vanguard Real Estate ETF
VNQ
$34.7B
| $856K | 0.01% |
+10,311
| New | +$856K |
|
|
ARRY
307
DELISTED
Array Biopharma Inc
ARRY
| $834K | 0.01% |
65,159
+29,312
| +82% | +$375K |
|
|
HSNI
308
DELISTED
HSN, Inc.
HSNI
| $810K | 0.01% |
20,072
-135,145
| -87% | -$5.45M |
|
|
SCG
309
DELISTED
Scana
SCG
| – | – |
-1,291,700
| Closed | -$63.3M |
|
|
INXN
310
DELISTED
Interxion Holding N.V.
INXN
| $693K | 0.01% |
11,760
-2,472
| -17% | -$146K |
|
311
Coherent
COHR
$15.2B
| $686K | 0.01% |
14,610
-1,240
| -8% | -$58.2K |
|
312
Advanced Drainage Systems
WMS
$11.5B
| $676K | 0.01% |
28,345
-364
| -1% | -$8.68K |
|
|
LJPC
313
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $670K | 0.01% |
20,812
+13,849
| +199% | +$446K |
|
|
AVXS
314
DELISTED
AveXis, Inc. Common Stock
AVXS
| $652K | 0.01% |
5,896
+3,258
| +124% | +$360K |
|
315
Oppenheimer Holdings
OPY
$765M
| $642K | 0.01% |
23,937
-9,255
| -28% | -$248K |
|
|
LOXO
316
DELISTED
Loxo Oncology, Inc
LOXO
| $625K | 0.01% |
7,429
+5,152
| +226% | +$433K |
|
|
RXDX
317
DELISTED
Ignyta, Inc.
RXDX
| $612K | 0.01% |
+22,936
| New | +$612K |
|
318
Dycom Industries
DY
$7.19B
| $595K | 0.01% |
5,343
-453
| -8% | -$50.4K |
|
319
Ultragenyx Pharmaceutical
RARE
$3.07B
| $580K | 0.01% |
12,509
+7,502
| +150% | +$348K |
|
320
Littelfuse
LFUS
$6.51B
| $565K | 0.01% |
2,854
-989
| -26% | -$196K |
|
321
Rogers Corp
ROG
$1.43B
| $560K | 0.01% |
3,459
-293
| -8% | -$47.4K |
|
322
Mercury Systems
MRCY
$4.13B
| $546K | 0.01% |
10,626
+1,178
| +12% | +$60.5K |
|
323
AbbVie
ABBV
$375B
| $537K | 0.01% |
5,555
| – | – |
|
324
Intel
INTC
$107B
| $530K | 0.01% |
11,478
| – | – |
|
325
ICU Medical
ICUI
$3.24B
| $518K | 0.01% |
2,399
-1,335
| -36% | -$288K |
|